A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis
C. Wang, P. Dulal, X. Zhou, Z. Xiang, H. Goharriz, A. Banyard, N. Green, L. Brunner, R. Ventura, N. Collin, S. J. Draper, A. V. Hill, R. Ashfield, A. R. Fooks, H. C. Ertl, A. Douglas
This paper develops a simian-adenovirus-vectored rabies vaccine that can be thermostabilized and administered as a single dose, showing potent immunogenicity and potential for low-cost pre-exposure prophylaxis.
bioRxiv · Sep 4, 2018Immunology